Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2009-07-21 20:29:00 UTC |
---|
Update Date | 2014-12-24 20:25:56 UTC |
---|
Accession Number | T3D3068 |
---|
Identification |
---|
Common Name | Silver sulfadiazine |
---|
Class | Small Molecule |
---|
Description | Silver sulfadiazine is only found in individuals that have used or taken this drug. It is a sulfa derivative topical antibacterial used primarily on second- and third-degree burns. [Wikipedia] Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. A specific mechanism of action has not been determined, but silver sulfadiazine's effectiveness may possibly be from a synergistic interaction, or the action of each component. Silver is a biocide, which binds to a broad range of targets. Silver ions bind to nucleophilic amino acids, as well as sulfhydryl, amino, imidazole, phosphate, and carboxyl groups in proteins, causing protein denaturation and enzyme inhibition. Silver binds to surface membranes and proteins, causing proton leaks in the membrane, leading to cell death. Sulfadiazine is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. |
---|
Compound Type | - Amide
- Amine
- Anti-Bacterial Agent
- Anti-Infective Agent, Local
- Antibiotic, Topical
- Drug
- Metabolite
- Organic Compound
- Sulfonamide
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | Dermazin | Flamazine | Silvadene | Silver sulfadiazinate | Silver sulphadiazine | Silverol | SSD | Sulfadiazine silver | Sulfadiazine silver salt | Thermazene |
|
---|
Chemical Formula | C10H9AgN4O2S |
---|
Average Molecular Mass | 357.137 g/mol |
---|
Monoisotopic Mass | 355.950 g/mol |
---|
CAS Registry Number | 22199-08-2 |
---|
IUPAC Name | silver(1+) ion 4-{[(pyrimidin-2-yl)azanidyl]sulfonyl}aniline |
---|
Traditional Name | silver(1+) ion sulfadiazinate |
---|
SMILES | [Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1 |
---|
InChI Identifier | InChI=1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1 |
---|
InChI Key | InChIKey=UEJSSZHHYBHCEL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzenesulfonamides |
---|
Direct Parent | Benzenesulfonamides |
---|
Alternative Parents | |
---|
Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- Aniline or substituted anilines
- Pyrimidine
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Heteroaromatic compound
- Organoheterocyclic compound
- Azacycle
- Organic transition metal salt
- Amine
- Organic salt
- Organic zwitterion
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Primary amine
- Organosulfur compound
- Organonitrogen compound
- Organic nitrogen compound
- Organic silver salt
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 285°C | Boiling Point | Not Available | Solubility | 7.87e+00 g/L | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udi-7691000000-b8839be77eb55e7132fd | 2017-08-28 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0ab9-0938000000-be4604140a2bd0588544 | 2017-09-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0ac0-3892000000-8b82e3b0d3290ae67890 | 2017-09-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0300-9500000000-b24ad6397d8c0c6084d5 | 2017-09-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0009000000-c97de297287bfe6e8b45 | 2017-09-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0udi-1409000000-b4bb7f26db83fdefa31d | 2017-09-01 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0f6x-9000000000-090eb04dca3a859505e6 | 2017-09-01 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Very limited penetration through the skin. Only when applied to very large area burns is absorption into the body generally an issue. |
---|
Mechanism of Toxicity | Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. A specific mechanism of action has not been determined, but silver sulfadiazine's effectiveness may possibly be from a synergistic interaction, or the action of each component. Silver is a biocide, which binds to a broad range of targets. Silver ions bind to nucleophilic amino acids, as well as sulfhydryl, amino, imidazole, phosphate, and carboxyl groups in proteins, causing protein denaturation and enzyme inhibition.
Silver binds to surface membranes and proteins, causing proton leaks in the membrane, leading to cell death.
Sulfadiazine is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. |
---|
Metabolism | The degradation of sulfonamides has two different pathways: the N-acetylation pathway which is genetically determined and saturable, and the cytochrome P450 pathway which produces toxic hydroxylamine metabolites "detoxified" by glutathione. (1) |
---|
Toxicity Values | LD50: 10001 mg/kg (oral, rat) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Health effects include areas of dead skin, red and raised rash on the body, and argyria (Skin discoloration). [Wikipedia] |
---|
Symptoms | Symptoms include burning sensation. [Wikipedia] |
---|
Treatment | Not Available |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB05245 |
---|
HMDB ID | HMDB15610 |
---|
PubChem Compound ID | 441244 |
---|
ChEMBL ID | CHEMBL1382627 |
---|
ChemSpider ID | 390017 |
---|
KEGG ID | Not Available |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 9142 |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Silver sulfadiazine |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Silver_sulfadiazine |
---|
References |
---|
Synthesis Reference | Charles L. Fox, Jr., Shanta M. Modak, Paul Fox, “Wound dressing comprising silver sulfadiazine incorporated in animal tissue and method of preparation.” U.S. Patent US4599226, issued September, 1977. |
---|
MSDS | Link |
---|
General References | - Mathelier-Fusade P, Leynadier F: [Intolerance to sulfonamides in HIV infected subjects. Toxic and allergic origin]. Presse Med. 1993 Oct 2;22(29):1363-5. [8248069 ]
- Fox CL Jr, Modak SM: Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother. 1974 Jun;5(6):582-8. [15825409 ]
- Russell AD, Hugo WB: Antimicrobial activity and action of silver. Prog Med Chem. 1994;31:351-70. [8029478 ]
- Percival SL, Bowler PG, Russell D: Bacterial resistance to silver in wound care. J Hosp Infect. 2005 May;60(1):1-7. [15823649 ]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|